CALR and impulse control disorder: Doxorubicin is fluorescent and incompatible for multicolor immunofluorescence imaging, thus we used oxaliplatin, a non-fluorescent and well-characterized ICD-inducing agent.32 First, we confirmed that surface CRT is induced in oxaliplatin-treated Jurkat cells, and that 9EG7 similarly inhibited surface CRT exposure (Figure 7a).